GHK-Cu is a naturally occurring copper-binding tripeptide that has attracted sustained research interest for over five decades. First isolated from human plasma in 1973 by Loren Pickart, the compound — a complex of the tripeptide Gly-His-Lys with a copper(II) ion — is found in plasma, saliva, and urine, and its concentration in plasma declines measurably with age. This age-related decline, combined with documented effects on wound healing, collagen synthesis, and gene expression, has made GHK-Cu one of the most studied endogenous peptides in aging and regenerative biology research.
For researchers investigating skin biology, tissue repair, antioxidant mechanisms, or the molecular biology of aging, GHK-Cu offers a well-characterized, naturally derived tool compound with one of the most extensive published literature bases of any short-chain peptide in current research use.
GHK-Cu is the copper(II) complex of the tripeptide glycine-histidine-lysine (GHK). The copper ion coordinates with the histidine imidazole nitrogen and the two flanking amino acid residues, forming a stable square-planar complex. This copper-chelating structure is central to the compound’s biological activity — the copper ion is not merely a cofactor but an integral part of the functional molecule.
In human plasma, GHK-Cu is present at concentrations of approximately 200 ng/mL in young adults, declining to roughly 80 ng/mL by age 60. This decline is considered biologically significant by researchers examining the relationship between endogenous peptide levels and age-related changes in tissue repair capacity and antioxidant defense. The compound is also found in wound fluid at elevated concentrations, suggesting a role in injury response signaling.
GHK-Cu is supplied for research as a blue-green lyophilized powder, reflecting the characteristic coloration of copper-peptide complexes. It is water-soluble and dissolves readily in aqueous buffer systems, making it practical to work with across a wide range of in vitro and ex vivo experimental designs.
| Property | Value |
|---|---|
| Full name | Copper(II) 3-aminopropanoyl-L-histidyl-L-lysine complex |
| Also known as | GHK-Cu, Copper Tripeptide-1, Gly-His-Lys:Cu(II) |
| Amino acid sequence | Gly-His-Lys (with coordinated Cu²⁺) |
| Molecular formula | C₁₄H₂₃CuN₆O₄⁺ |
| Molecular weight | 403.92 g/mol (copper complex) |
| CAS number | 49557-75-7 |
| Purity (Official Peptides) | >99% by HPLC |
| Physical form | Blue-green lyophilized powder |
| Solubility | Water soluble |
| Storage (lyophilized) | 2–8°C, protected from light |
| Storage (reconstituted) | 4°C, use within 7 days; prepare fresh where possible |
The most extensively documented area of GHK-Cu research concerns its role in wound healing and extracellular matrix remodeling. Early studies by Pickart and colleagues established that GHK stimulates collagen synthesis in fibroblast cultures, and subsequent decades of research have refined understanding of the specific pathways involved.
Research has documented GHK-Cu’s ability to upregulate the synthesis of collagen, elastin, and glycosaminoglycans — the primary structural proteins of the extracellular matrix. In wound healing models, treated groups have shown accelerated wound closure rates, increased fibroblast proliferation and migration, and improved tensile strength of healed tissue. Studies examining dermal repair have reported enhanced deposition of collagen type I and type III, with improved fiber organization compared to untreated controls.
Of particular interest to researchers studying scar formation is GHK-Cu’s apparent dual effect on collagen: stimulating new synthesis while simultaneously upregulating metalloproteinase enzymes (MMP-2 and MMP-9) that remodel excess collagen. This balanced regulation of collagen metabolism has made GHK-Cu a subject of investigation in both wound healing acceleration and hypertrophic scar reduction models.
The age-related decline in plasma GHK-Cu concentrations has motivated research into whether this peptide plays a functional role in maintaining skin integrity and repair capacity with advancing age. Studies have examined GHK-Cu’s effects on dermal fibroblast function, keratinocyte behavior, and the structural proteins that determine skin mechanical properties.
Research has documented GHK-Cu’s stimulatory effects on decorin expression — a proteoglycan involved in collagen fiber organization and TGF-β signaling regulation. Studies examining its effects on epidermal keratinocytes have reported enhanced migration and proliferation in treated cultures, with implications for epidermal barrier restoration following injury.
Investigations into GHK-Cu’s effects on skin-relevant gene expression have shown modulation of pathways associated with basement membrane integrity, including upregulation of laminin and fibronectin synthesis. The compound has also been studied for its effects on sebaceous gland function and hair follicle biology in ex vivo models.
GHK-Cu’s antioxidant properties have been the subject of sustained research interest. The compound has been shown to upregulate the expression of antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase in cell culture models — effects that have been replicated across multiple cell types including fibroblasts, endothelial cells, and neuronal cell lines.
Anti-inflammatory research has examined GHK-Cu’s effects on NF-κB pathway activation and pro-inflammatory cytokine expression. Studies in macrophage models have reported reduced TNF-α and IL-1β secretion in GHK-Cu-treated groups following inflammatory challenge. Research has also documented interactions with TGF-β1 signaling, where GHK-Cu appears to modulate the pro-fibrotic and pro-inflammatory aspects of TGF-β1 activity while preserving its wound healing-relevant signaling functions.
Perhaps the most striking finding in recent GHK-Cu research involves its effects on genome-wide gene expression. A series of studies using microarray and RNA sequencing approaches has documented GHK-Cu’s effects on the expression of thousands of genes in human cell models — an unusually broad transcriptional footprint for a tripeptide.
Research by Lunde et al. and subsequent investigators has reported that GHK-Cu modulates gene expression networks associated with DNA repair, mitochondrial function, ubiquitin-proteasome system activity, and inflammatory signaling. Analyses of these transcriptomic data have noted overlap between genes regulated by GHK-Cu and those associated with longevity and healthspan in model organisms — an observation that has driven significant interest in the compound within aging biology research.
Studies have specifically documented GHK-Cu-induced upregulation of genes encoding DNA repair enzymes, mitochondrial complex components, and heat shock proteins, alongside downregulation of genes associated with cancer progression, oxidative damage, and systemic inflammation — findings that have positioned GHK-Cu as a compound of broad research interest beyond its original wound healing applications.
More recent research has examined GHK-Cu in the context of neurological protection. Cell culture studies have reported neuroprotective effects against oxidative stress-induced neuronal death, with GHK-Cu-treated neurons showing increased survival rates following hydrogen peroxide and other oxidative challenges.
Research has also examined GHK-Cu’s potential interactions with neurotrophic factor expression, with some studies reporting upregulation of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)-related pathways in treated cell models. The compound’s antioxidant enzyme upregulation properties are considered potentially relevant to oxidative stress-driven neurodegeneration models, though this remains an early-stage area of investigation relative to the skin biology literature.
The concept of GHK-Cu as a broad modulator of gene expression — rather than a compound with a single defined receptor target — distinguishes it from most research peptides and has been the subject of significant scientific discussion. The transcriptomic data suggesting widespread gene regulatory activity raises fundamental questions about the compound’s mechanism: how does a tripeptide with no classical receptor produce such broad transcriptional effects?
Current research hypotheses center on GHK-Cu’s interaction with copper-dependent regulatory enzymes, its potential role as an epigenetic modulator through effects on chromatin remodeling enzymes, and its documented interactions with signaling hubs such as TGF-β and NF-κB that regulate large networks of downstream gene expression. The copper ion is considered integral to these mechanisms — copper-free GHK shows reduced activity in many assay systems, confirming that metal coordination is functionally essential rather than incidental.
Researchers have also noted the alignment between GHK-Cu’s transcriptional effects and the patterns of gene expression associated with biological youth in human tissue — a finding that has attracted attention from longevity researchers examining whether endogenous age-declining peptides like GHK-Cu play a causal role in aging biology rather than merely serving as markers of it.
GHK-Cu’s copper-chelating structure provides some protection against peptide degradation, but the compound requires careful handling to maintain activity in solution. The copper ion can catalyze oxidative reactions in the presence of peroxides — researchers should avoid exposure to hydrogen peroxide-containing buffers and ensure that working solutions are prepared in appropriate aqueous vehicles.
Key research considerations for GHK-Cu:
Freshness of reconstituted solutions: GHK-Cu in solution is susceptible to gradual oxidation, particularly at neutral to alkaline pH. Where experimental design permits, prepare working solutions fresh immediately before use. If storage is necessary, maintain at 4°C in sealed, light-protected containers for no more than 7 days.
Adsorption to labware: At low working concentrations, GHK-Cu can adsorb to plastic surfaces. Researchers working at sub-micromolar concentrations should consider siliconized tubes or protein-containing buffer systems to minimize compound loss to surfaces during experimental procedures.
Copper ion considerations: In copper-sensitive biological assay systems, the copper component of GHK-Cu may confound results if not properly controlled. Free copper controls should be included in experimental designs where copper ion activity cannot be excluded as a contributing variable.
Concentration ranges in published literature: Published research on GHK-Cu spans a wide concentration range from nanomolar to micromolar. Researchers should review existing literature for their specific cell or tissue model to identify concentration ranges that have shown biological activity without cytotoxic effects.
Purity verification: HPLC-verified purity at >99% is important for GHK-Cu research, as copper-containing impurities can produce significant biological artifacts in antioxidant and cytotoxicity assays. COA documentation from an independent laboratory should be requested and reviewed before use.
Official Peptides supplies GHK-Cu at >99% purity verified by HPLC and mass spectrometry, with batch-specific certificate of analysis documentation available for every purchase. Our GHK-Cu is manufactured under controlled conditions and ships from a US-based facility with cold pack packaging to maintain compound integrity during transit.
Researchers sourcing GHK-Cu for ongoing studies benefit from our consistent batch-to-batch quality standards and same-day dispatch on qualifying orders. For volume requirements or custom formulations, contact our research supply team directly.
All content is provided for research reference purposes only. For in vitro laboratory research use only.